Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03088891
Other study ID # ALTAX
Secondary ID
Status Completed
Phase N/A
First received September 20, 2016
Last updated March 19, 2017
Start date October 2015
Est. completion date November 2015

Study information

Verified date March 2017
Source University of Oslo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Athletes, especially in endurance sports, are at increased risk of oxidative stress and inflammation-related diseases and injuries. The production of reactive oxygen and nitrogen species (RONS) and inflammatory markers increase during exercise and especially during altitude training. Antioxidant supplementation is commonly used among athletes in the belief that it prevents oxidative stress and oxidative damage. A transient increase of RONS is however necessary to activate signaling cascades initiating training adaptation. Antioxidant supplementation has been shown to inhibit the exercise effects in several independent studies, possibly by interfering/reducing the signal cascades initiated by RONS. However, it is unknown whether a high intake of antioxidant rich foods can affect the amount of RONS, inflammation markers and/or training adaptation. The investigators want to examine whether an increased intake of natural antioxidants in the form of antioxidant-rich foods fruits, vegetables and berries, in line with the official Norwegian dietary advice can affect antioxidant status, immune function and training adaptation associated with altitude training in Norwegian elite athletes.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date November 2015
Est. primary completion date November 2015
Accepts healthy volunteers No
Gender All
Age group 16 Years to 42 Years
Eligibility Inclusion Criteria:

- National team athletes, summer endurance sports

Exclusion Criteria:

- Allergies in conflict with the intervention foods

- Use of medication that could affect training and performance

- Injuries that could affect training and performance

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Antioxidant-rich snacks
Bama Smoothies (Bama, Oslo, Norway), Freia Premium Dark Chocolate (Freia, Oslo, Norway), Walnuts (Eldorado, Norway), Dried fruits and berries (Cranberries, Gojiberries, apricots)(Bama, Oslo, Norway and Rema 1000, Norway)
Control snacks
Milkshake (Tine, Oslo, Norway), YT restitusjonsdrikk (Tine, Oslo, Norway), Bixit (Sætre, Oslo, Norway), Ritz (Mondelez, Oslo, Norway), White chololate (Freia, Oslo, Norway)

Locations

Country Name City State
Norway Norwegian Olympic Federation Oslo
Norway University of Oslo Oslo

Sponsors (3)

Lead Sponsor Collaborator
University of Oslo Norwegian Olympic Federation, Oslo, Norway, Norwegian School of Sport Sciences

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percent change in performance (sport specific tests will be aggregated to one outcome by the use of percent change) Cycling: 10 000 m on a bike roller; Rowing: 2000 meter on Concept2-apparatus; Paddling: 1000 meter Concept2-apparatus; Swimming: 200 meter Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Primary Training adaptation change in Vo2-max Measured one week before, and one week after the moderate altitude training camp
Primary Training adaptation for swimmers For swimming only: 100 meter max speed Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary Change in biomarkers of inflammation change in cytokine profile e.g. IL-6 ,TNF, CRP measured by multiplex technology Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary change in lean body mass measured by DXA (iDXA; GE Healthcare) Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary Bone mineral density measured by DXA (iDXA; GE Healthcare) Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary change in fat mass measured by DXA (iDXA; GE Healthcare) Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary change in body composition measured by DXA (iDXA; GE Healthcare) Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary change in body weight measured by standardized scale Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary Dietary intake (change in food and nutrient intake) measured by repeated 24 hour recalls Measured one and three week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary Change in antioxidant status e.g. FRAP, ORAC, dROM, isoprostanes measured by HPLC Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary biomarkers of antioxidant-rich foods e.g. carotenoids, flavonoids measured by HPLC Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary Change in whole blood gene expression Fasting blood samples (PAX-tubes) and samples taken after physical stress test (PAX-tubes). RNA will be isolated and gene expression measured Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary Change in blood lipids Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary Change hormones Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary Change in micronutrients e.g. iron status Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary change response to stress test Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary Change in hemoglobin CO-rebreathing-method Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary change in blood volume CO-rebreathing-method Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary change in plasma volume CO-rebreathing-method Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary Change in lactate Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
Secondary Total training load Training diary Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp
See also
  Status Clinical Trial Phase
Completed NCT03995979 - Inflammation and Protein Restriction N/A
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT03577223 - Egg Effects on the Immunomodulatory Properties of HDL N/A
Completed NCT04383561 - Relationship Between LRG and Periodontal Disease N/A
Active, not recruiting NCT03622632 - Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT04856748 - Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
Completed NCT05529693 - Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population N/A
Recruiting NCT05670301 - Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases N/A
Recruiting NCT05415397 - Treating Immuno-metabolic Depression With Anti-inflammatory Drugs Phase 3
Recruiting NCT04543877 - WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study Early Phase 1
Recruiting NCT05775731 - Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03429920 - Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors N/A
Completed NCT06065241 - Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals. N/A
Completed NCT05864352 - The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
Completed NCT03318731 - Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males N/A
Not yet recruiting NCT06134076 - Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota N/A
Not yet recruiting NCT06422494 - The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II N/A